Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: A randomized controlled trial

ABSTRACT

Objective: To compare and study the dipeptidy1 peptidase‑4 (DPP‑4) inhibitors in combination with metformin against established combination therapies. Materials and Methods: This 16‑week study was designed to compare sitagliptin versus pioglitazone as add‑on therapy in patients of type 2 diabetes mellitus inadequately controlled with metformin alone. Fifty‑two patients were randomized into two groups to receive either sitagliptin 100 mg (group 1) or pioglitazone 30 mg (group 2) in addition to metformin. The primary efficacy end point was change in HbA1c. Secondary end points included change in fasting plasma glucose (FPG), body weight and lipid profile. Treatment satisfaction was assessed using the Diabetes Treatment Satisfaction Questionnaire. Both the groups had a significant decrease in HbA1c. Results: There was no significant difference between mean reductions in FPG in both the groups. There was a significant decrease in the mean body weight and body mass index in group 1 in contrast to the significant increase in the same in group 2. Both the treatment groups reported a significant decrease in High‑density lipoprotein (HDL‑C) and Triglyceride. Conclusion: Sitagliptin was well tolerated without any incidence of hypoglycemia. It was concluded that sitagliptin as an add‑on to metformin is as effective and well tolerated as pioglitazone.

KEYWORDS

• DPP-4 inhibitors
• diabetes mellitus
• add-on therapy

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.4103/0976-500X.107656Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Article · VOLUME 4, ISSUE 1Effect of Casilan® on 13C-caffeine metabolism in overnight-fasted healthy Nigerian childrenKazeem A. Oshikoya, Ken Smith · pp. 19–26Research PaperSame type: Article
• Article · VOLUME 4, ISSUE 1Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectorisAditi Chaturvedi, Yogendra Singh, Harish Chaturvedi, Vijay Thawani, Sakshi Singla, Deepak Parihar · pp. 33–33Research PaperSame type: Article
• Article · VOLUME 4, ISSUE 1Efficacy and safety of Tinospora cordifolia lotion in Sarcoptes scabiei var hominis‑infected pediatric patients: A single blind, randomized controlled trialAgnes L. Castillo, Marina O. Osi, John Donnie A. Ramos, Jean L. De Francia, Marylaine U. Dujunco, Peter F. Quilala · pp. 39–46Research PaperSame type: Article
• Article · VOLUME 4, ISSUE 1Oleanolic acid prevents progression of streptozotocin induced diabetic nephropathy and protects renal microstructures in Sprague Dawley ratsVishal K. Dubey, Chandragouda R. Patil, Sarika M. Kamble, Priti S. Tidke, Kalpesh R. Patil, Pragnesh J. Maniya, Ramchandra B. Jadhav, Sudha P. Patil · pp. 47–52Research PaperSame type: Article